Bioactivity | ARF(26–44), cell-permeable is a cell-penetrating peptide derived from a specific amino acid sequence of the p14ARF tumor suppressor protein. As a functional inhibitor of FoxM1, ARF(26–44) cell-permeable shows significant anti-tumor activity in the treatment of mouse hepatocellular carcinoma (HCC), significantly increasing tumor cell apoptosis and reducing tumor cell proliferation and angiogenesis. ARF(26–44), cell-permeable can be used in research on tumor therapy[1]. |
CAS | 935732-44-8 |
Sequence | {d-(Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg)}-Lys-Phe-Val-Arg-Ser-Arg-Arg-Pro-Arg-Thr-Ala-Ser-Cys-Ala-Leu-Ala-Phe-Val-Asn |
Shortening | {d-(Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg)}-KFVRSRRPRTASCALAFVN |
Formula | C149H267N69O33S |
Molar Mass | 3585.22 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Gusarova G A, et al. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment[J]. The Journal of clinical investigation, 2007, 117(1): 99-111. |